— Tobias B. Huber, MD
Created with BioRender
We aim at a better understanding of podocytopathies, the identification of complex principles of kidney diseases, immune -tissue interactions and interorgan signaling. For this purpose, our lab is advancing the following research areas:
With this, our aim is to identify new approaches for the prevention, halt and cure of kidney diseases.
Chair of the Center of Internal Medicine
Director of the III. Department of Medicine
III. Department of Medicine, University Medical Center Hamburg-Eppendorf (UKE)
Martinistr. 52
20246 Hamburg, Germany
Chair of the Center of Internal Medicine
Director of the III. Department of Medicine
1992 - 1999 | School of Medicine (10/1992-05/1999), Universities of Freiburg, Vienna (Austria) and South Florida (Tampa, USA) |
2020 - 2020
|
Chair of the Center of Internal Medicine, UKE |
2017
|
Director of the III. Department of Medicine, UKE |
2015
|
Chief of the Division of Chronic Kidney Disease, University Medical Center Freiburg (UKF), Germany |
2013
|
W3 Heisenberg Professor, UKF |
2008
|
German Board Certification for Internal Medicine (2008) and Nephrology (2011) |
2007
|
Habilitation, UKF |
2005
|
USMLE US-American Full Medical Licence |
1999
|
MD in Physiology (summa cum laude), Department of Physiology, UKF |
Clinical postgraduate education:
2015 - 2017 | Deputy Chair, Department of Medicine IV, UKF |
2011 - 2015 | Senior Attending (Geschäftsführender Oberarzt), UKF |
2008 - 2011 | Attending Physician, Department of Medicine IV, UKF |
2001 - 2003 | Fellow in Medicine, Department of Medicine IV, UKF |
1999 - 2001 | Residency, Department of Medicine IV, UKF |
Scientific postgraduate education:
2013 - 2017 | W3 Heisenberg Professorship, UKF |
2006 - 2011 | Emmy Noether Programme – Phase II / Group leader, UKF |
2003 - 2006 | Emmy Noether Programme – Phase I / Postdoctoral Fellow, Immunology & Pathology, Washington University St. Louis, USA (Laboratory of Prof. Dr. A. Shaw) |
2021 - 2020
|
Elected Member of the National Academy of Sciences – Leopoldina- |
2021
|
Elected Member of the American Association of Physicians |
2021
|
Chair Else Kröner-Fresenius Clinician-Scientist Kolleg “iPRIME-CS”, UKE |
2021
|
Co-Chair BMBF-Advanced Clinician Scientist Program “iSTAR”, UKE |
2020
|
Speaker (together with U. Panzer) of the CRC 1192 |
2020
|
DFG-Senate Commission on Key Questions in Clinical Research |
2018
|
Chair Else Kröner-Fresenius MD-Thesis Kolleg “iPRIME”, UKE |
2016
|
Co-Chair Else Kröner-Fresenius Kolleg “NAKSYS”, UKF |
2014
|
Recipient of the European Research Council Grant |
2014
|
Elected Member of the American Society of Clinical Investigation |
2012
|
Young Investigator Award of the American Society of Nephrology (considered the worldwide highest award for renal research < 45 years) |
2010
|
Franz-Volhard Award of the German Renal Society |
2009
|
Hans U. Zollinger Research Award of German Renal Society |
2008
|
Associated Member of the BIOSS Excellence Cluster, Freiburg |
2006
|
Principal Investigator of the SGBM Graduate School, Freiburg |
2004
|
Carl Ludwig Award of the German Renal Society |
1. | Hengel FE, Dehde S, Lassé M, Zahner G, Seifert L, Schnarre A, Kretz O, Demir F, Pinnschmidt HO, Grahammer F, Lucas R, Mehner LM, Zimmermann T, Billing AM, Oh J, Mitrotti A, Pontrelli P, Debiec H, Dossier C, Colucci M, Emma F, Smoyer WE, Weins A, Schaefer F, Alachkar N, Diemert A, Hogan J, Hoxha E, Wiech T, Rinschen MM, Ronco P, Vivarelli M, Gesualdo L, Tomas NM, Huber TB; International Society of Glomerular Disease. N Engl J Med. 2024 Aug 1;391(5):422-433. |
2. | Accumulation of α-synuclein mediates podocyte injury in Fabry nephropathy.
Braun F, Abed A, Sellung D, Rogg M, Woidy M, Eikrem O, Wanner N, Gambardella J, Laufer SD, Haas F, Wong MN, Dumoulin B, Rischke P, Mühlig A, Sachs W, von Cossel K, Schulz K, Muschol N, Gersting SW, Muntau AC, Kretz O, Hahn O, Rinschen MM, Mauer M, Bork T, Grahammer F, Liang W, Eierhoff T, Römer W, Hansen A, Meyer-Schwesinger C, Iaccarino G, Tøndel C, Marti HP, Najafian B, Puelles VG, Schell C, Huber TB. J Clin Invest. 2023 Jun 1;133(11):e157782. doi: 10.1172/JCI157782. |
3. | Expansion-enhanced super-resolution radial fluctuations enable nanoscale molecular profiling of pathology specimens.
Kylies D, Zimmermann M, Haas F, Schwerk M, Kuehl M, Brehler M, Czogalla J, Hernandez LC, Konczalla L, Okabayashi Y, Menzel J, Edenhofer I, Mezher S, Aypek H, Dumoulin B, Wu H, Hofmann S, Kretz O, Wanner N, Tomas NM, Krasemann S, Glatzel M, Kuppe C, Kramann R, Banjanin B, Schneider RK, Urbschat C, Arck P, Gagliani N, van Zandvoort M, Wiech T, Grahammer F, Sáez PJ, Wong MN, Bonn S, Huber TB, Puelles VG. Nat Nanotechnol. 2023 Apr;18(4):336-342. doi: 10.1038/s41565-023-01328-z. |
4. | Loss of the collagen IV modifier prolyl 3-hydroxylase 2 causes thin basement membrane nephropathy Aypek H, Krisp C, Lu S, Liu S, Kylies D, Kretz O, Wu G, Moritz M, Amann K, Benz K, Tong P, Hu ZM, Alsulaiman SM, Khan AO, Grohmann M, Wagner T, Müller-Deile J, Schlüter H, Puelles VG, Bergmann C, Huber TB, Grahammer F. J Clin Invest. 2022 May 2;132(9):e147253. doi: 10.1172/JCI147253. |
5. | Molecular consequences of SARS-CoV-2 liver tropism. |
6. | Pro-cachectic factors link experimental and human chronic kidney disease to skeletal muscle wasting programs. |
7. | Decoding myofibroblast origins in human kidney fibrosis. |
8. | Podocytes maintain high basal levels of autophagy independent of mtor signaling. |
9. | SARS-CoV-2 renal tropism associates with acute kidney injury. |
10. | Multiorgan and Renal Tropism of SARS-CoV-2. |
Martinistraße 52
Campus Research N27
20246 Hamburg Germany